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First described by Carlos Justiniano Ribeiro Chagas 
(1879-1934) in 1909, Chagas disease (CD) or American 
trypanosomiasis is caused by the protozoan parasite 
Trypanosoma cruzi. This zoonotic infectious disease 
follows a sylvatic cycle where blood-sucking triatomine 
insect (known as kissing bug or in Portuguese as 
“barbeiro”), acquire the parasite by sucking small 
mammals’ blood and transmit to humans through 
their feces, left close to the bite site. The parasite, 
in turn, reaches the human blood stream when the 
parasite-laden feces are dispersed at the itching 
bite wound. More rarely, transmission may also 
occur through blood transfusion, congenital, organ 
transplantation and oral transmission by ingesting 
contaminated food by infected triatomine or their 
feces. In addition, the disease may reactivate from 
the chronic phase when  associated with any sort of 
immunosuppression, including HIV infection.1
In 2012 it was estimated that 8 million persons 
were infected in South and Central America and 
Mexico and that 12,500 deaths occur annually due to 
Chagas disease.2
The natural history of the disease involves an 
acute phase that lasts between 8 and 12 weeks after 
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Gross findings of Chronic Chagas Cardiomiopathy. A – “Chagasic rosary” represented by small round whitish 
granules deposited sequentially along the coronary vessels. B and C – Dilation of the atrial and ventricular chambers 
with typical apical left ventricular aneurysm in C. Image courtesy Dr. Vera Demarchi Aiello. 
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an incubation period of two weeks. However, in case 
of transmission by transfusion or transplant-associated 
cases this incubation period may be much longer.3,4 
This phase is characterized by parasitemia, and 
therefore the diagnosis can be made by detection, 
on microscopy, of circulating parasites in fresh 
blood or buffy coat smears. The acute phase may 
be asymptomatic or may present nonspecific clinical 
features. Meanwhile, severe acute Chagas disease, 
hopefully rare (less than 1% of the cases), may present 
as acute myocarditis, pericardial effusion and/or 
meningoencephalitis, which is associated with high 
risk of death.5
The chronic phase begins from the moment at 
which the parasitemia falls and is no longer detectable 
by microscopy, in the absence of specific therapy. 
If patients, after the resolved acute infection, do 
not present signs of heart or gastrointestinal disease 
they are considered to have the indeterminate form. 
Although asymptomatic, autopsy studies performed 
in patients with the indeterminate form who died 
from accidental causes revealed the presence of 
scattered myocardial inflammatory sites.6,7 In the study 
conducted by Macedo,8-10 in São Felipe (BA), which 
comprised 400 patients with the indeterminate form of 
Chagas disease, 24% developed clinical disease after 
10 years. This percentage is higher among younger 
patients.
The major manifestat ions of chronic CD 
comprise cardiomyopathy (much more frequent) and 
gastrointestinal disease, mainly characterized by the 
presence of dilations (mega esophagus or mega colon).
Chronic Chagas cardiomyopathy (CCC) may 
be manifested, isolated or concurrently, by heart 
failure, arrhythmias, thromboembolism (systemic or 
pulmonary) and chest pain. Therefore clinical features 
are characterized by fatigue, dyspnea, peripheral 
edema, pulmonary rales, ascites, hepatomegaly, 
increased jugular venous pressure, palpitation, 
syncope and cardiac arrest,the latter responsible 
for up to half of the deaths.11 All types of atrial and 
ventricular arrhythmias may be virtually present. 
Atrioventricular and bundle blocks are also often 
present.12 Thromboembolism is an important cause 
of CCC morbidity. Stroke may be due to embolus 
originated in left ventricular aneurysm or dilated left 
chamber, and pulmonary thromboembolism arises 
from right heart thrombi due to chamber dilation or 
atrial fibrillation. In a retrospective and large study on 
autopsies of patients with CCC intracardiac thrombi 
were observed in 44% of cases.13
Gross morphological features of CCC include 
severe dilation of the atrial and ventricular chambers 
(Figure, panels B and C), with the typical apical left 
ventricular aneurysm, a lesion where the ventricular 
wall is thinned and partially or completely replaced by 
fibrosis (Figure, panel C). Other areas of wall thinning 
are also observed, mainly at the diaphragmatic wall 
near the left atrioventricular junction. Thrombosis is 
frequent both inside the atrial appendages and filling 
the apical aneurysm. On the epicardial surface some 
frequent findings are focal areas of fibrous thickening, 
the so called “milky spots”, usually found on the 
anterior surface of the right ventricle, and lesions 
known as the “Chagasic rosary” (Figure, panel A) 
appearing as round whitish granules along the 
epicardial course of the coronary vessels in up to 
one quarter of the cases.14 At microscopy, there is 
diffuse chronic myocarditis with variable degrees of 
fibrosis. The finding of parasites in the myocardium 
is rare, and usually disproportional to the intensity of 
the inflammation, a fact that led to the hypothesis 
of autoimmunity in the pathogenesis of the disease. 
Higuchi and co-workers believe that the presence of the 
parasite or its antigens in the myocardium, although 
in small quantities, is important for the maintenance 
of the inflammatory process.15 Inflammation and 
fibrosis may involve the atrioventricular node and 
bundle branches, causing cardiac block. Segmental 
and irregular fibrosis of the ventricular walls may also 
elicit sustained ventricular tachycardia, since isolated 
myocardial cells remain as islands or peninsulas within 
the fibrotic areas, similar to what occurs in healed 
myocardial infarction.
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